用于治疗失眠的dimdazenil:一个系统的审查和叙事合成
Shan Ran1, Shouhuan Liu2, Kewen Yan2,3
1Psychiatric Hospital of Ziyang, Ziyang, 641300, Sichuan, China.
概括
迪姆达泽尼尔通过改善睡眠开始和维持而有效治疗失眠,而不会引起白天的昏昏欲睡. 这种新的失眠治疗方法显示出良好的安全性,尽管仍需要长期数据.
科学领域:
- 药理学 药理学是指药理学的学科.
- 睡眠医学 睡眠医学
- 临床试验 临床试验
背景情况:
- 失眠影响全球10-20%的成年人,治疗疗效和功能障碍的需求尚未得到满足.
- 目前的失眠治疗方法在改善睡眠维持和减少白天功能障碍方面存在局限性.
研究的目的:
- 系统地审查和综合关于Dimdazenil在治疗失眠的疗效和安全性的证据.
- 评估Dimdazenil对睡眠参数和白天功能的影响.
主要方法:
- 一个全面的文献搜索确定了四个随机对照试验 (RCT) 的合成.
- 由于有限的定量数据,采用了叙事综合.
主要成果:
- 迪姆达泽尼尔显著改善了客观和主观的睡眠指标,包括减少睡眠延迟和增加总睡眠时间.
- 该药物表现出可接受的安全性,没有明显的过度白天嗜睡或功能障碍.
- 在退出,残留或反弹效应指标中没有观察到显著差异.
结论:
- 迪姆达泽尼尔在改善失眠患者的睡眠开始和维持方面表现有前途.
- 它提供了有利的安全性和耐受性,保持了白天的功能.
- 建议进一步进行大规模的长期研究,以评估多样化的人口.
相关概念视频
Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Sedatives and Hypnotics: Overview
279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
Sedatives and Hypnotics Drugs: Benzodiazepines
194
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
194
CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224
Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79


